Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CRNX

Crinetics Pharmaceuticals Inc

May 29 • 04:00PM ET

35.55

-0.46 -1.28 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: RYTM MIRM VKTX BMRN AXSM KRYS MDGL NBIX INCY ALNY

| Held by: VTI VB IWM VBK VXF IWO IBB VTWO SCHA VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-5.13	Insider Own	7.36%	Shs Outstand	105.31M	Perf Week	-4.15%
Market Cap	3.75B	Forward P/E	-	EPS next Y	-4.21	Insider Trans	-1.89%	Shs Float	97.68M	Perf Month	-7.52%
Enterprise Value	2.50B	PEG	-	EPS next Q	-1.22	Inst Own	113.20%	Short Float	13.49%	Perf Quarter	-13.50%
Income	-496.39M	P/S	207.44	EPS this Y	2.99%	Inst Trans	9.40%	Short Ratio	10.96	Perf Half Y	-20.49%
Sales	18.07M	P/B	2.92	EPS next Y	12.42%	ROA	-35.94%	Short Interest	13.18M	Perf YTD	-23.63%
Book/sh	12.16	P/C	2.90	EPS next 5Y	22.72%	ROE	-39.17%	52W High	57.99 -38.70%	Perf Year	16.48%
Cash/sh	12.25	P/FCF	-	EPS past 3/5Y	-16.20% -15.33%	ROIC	-37.55%	52W Low	25.83 37.63%	Perf 3Y	60.86%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	17.56% -	Gross Margin	70.11%	Volatility	3.15% 5.35%	Perf 5Y	102.56%
Dividend TTM	-	EV/Sales	138.62	EPS Y/Y TTM	-34.49%	Oper. Margin	-3020.32%	ATR (14)	1.76	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	18.56	Sales Y/Y TTM	4905.26%	Profit Margin	-2747.18%	RSI (14)	41.33	Recom	1.19
Dividend Gr. 3/5Y	- -	Current Ratio	18.60	EPS Q/Q	-18.15%	SMA20	-5.78%	Beta	0.25	Target Price	83.14
Payout	-	Debt/Eq	0.04	Sales Q/Q	2873.41%	SMA50	-5.87%	Rel Volume	1.42	Prev Close	36.01
Employees	594	LT Debt/Eq	0.03	Earnings	May 07 AMC	SMA200	-14.26%	Avg Volume	1.20M	Price	35.55
IPO	Jul 18, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-0.70% 26.07%	Trades		Volume	1,709,475	Change	-1.28%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)